NASDAQ: CNSP
Cns Pharmaceuticals Inc Stock Ownership - Who owns Cns Pharmaceuticals?

Insider buying vs selling

Have Cns Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CNSP insiders and whales buy or sell their stock.

CNSP Shareholders

What type of owners hold Cns Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cortice Biosciences Inc99.79%573,368$3.59MInsider
Armistice Capital LLC70.66%406,000$2.54MInstitution
John M. Climaco37.54%215,676$1.35MInsider
Waldemar Priebe27.29%156,807$982.40kInsider
Christopher Downs18.00%103,438$648.04kInsider
Jerzy Gumulka7.48%43,006$269.43kInsider
Carl Anthony Evans5.82%33,458$209.61kInsider
Ubs Group Ag5.59%32,103$201.13kInstitution
Virtu Financial LLC4.06%23,348$146.28kInstitution
Geode Capital Management LLC3.11%17,871$111.96kInstitution

1 of 2

CNSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNSP31.08%68.92%
JAGX0.13%99.87%
ENTO2.06%97.94%Net Selling
GRI0.71%99.29%
ENVB7.21%16.79%

Cns Pharmaceuticals Stock Ownership FAQ

Who owns Cns Pharmaceuticals?

Cns Pharmaceuticals (NASDAQ: CNSP) is owned by 89.24% institutional shareholders, 197.86% Cns Pharmaceuticals insiders, and 0.00% retail investors. Cortice Biosciences Inc is the largest individual Cns Pharmaceuticals shareholder, owning 573,368.00 shares representing 99.79% of the company. Cortice Biosciences Inc's Cns Pharmaceuticals shares are currently valued at $3.55M.

If you're new to stock investing, here's how to buy Cns Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.